Correspondingly, >75% of both prospective and in vitro isolated BM MSC populations (the sorted RFP+ cells and in vitro RFP+ MSC) that were recruited to the tumor microenvironment co-expressed FAP and FSP (Figure 3). The gene discussed is CXCL1; the disease is neoplasm.